RVP-001

DRUG2 trials

Sponsors

Reveal Pharmaceuticals Inc.

Conditions

Acoustic NeuromaBrain CancerBrain MetastasesBrain Neoplasm, PrimaryBrain NeoplasmsBrain Neoplasms, BenignBrain TumorBrain Tumor, Primary

Phase 1

First in Human Study of RVP-001, a New Manganese Based MRI Contrast Agent

CompletedNCT05413668

Reveal Pharmaceuticals Inc.Healthy

Start: 2022-05-18End: 2022-08-22Updated: 2025-04-22

Phase 2

Phase 2 Ascending Dose Safety and Efficacy Study of RVP-001, a Manganese-based MRI Contrast Agent

CompletedNCT06322342

Reveal Pharmaceuticals Inc.Acoustic Neuroma, Brain Cancer, Brain Metastases +22

Start: 2024-08-15End: 2025-12-19Updated: 2025-12-26